The third in our ‘TB Talk’ series, we hear from Dr. Malcolm King, a professor in the Faculty of Health Sciences at Simon Fraser University. He discusses the importance of social determinants of health to the rate of new TB infections and better TB outcomes in remote, northern and Indigenous communities.
Subject Area: Tuberculosis (TB)
IQ10: Tuberculosis and Cultural Humility (TB Talk, Pt 2)
This episode continues our look at tuberculosis at End TB 2017, a meeting of the North American Region of the International Union Against Tuberculosis. Our guest, Kay Wallis, is a special projects manager with the Curry International Tuberculosis Center. She presented on cultural proficiency among healthcare providers, or, as she calls it, cultural humility.
Latent Tuberculosis Infection (LTBI) Management at BridgeCare Clinic (Full Report)
An in-depth review and analysis of the model of latent tuberculosis infection management and promising treatment completion outcomes at BridgeCare Clinic in Winnipeg, Canada.
Integrated LTBI Care for Refugees: Successes & Challenges at BridgeCare Clinic in Winnipeg
In this case study, we share the story of the success of BridgeCare Clinic, a model of integrated TB services for government-assisted refugees for its approach to improving latent tuberculosis infection (LTBI) treatment completion outcomes in priority populations.
IQ9: Tuberculosis priorities at End TB 2017 (TB Talk, Pt 1)
This episode, we turn our attention to tuberculosis. This February, the city of Vancouver played host to End TB 2017, a meeting of the International Union Against Tuberculosis, specifically, the North American Region. We hear a sample of attendees’ top TB priorities. In future episodes, we’ll bring you a number of one-on-one conversations with experts at the meeting.
Treatment as Prevention: Containment of TB, HIV and Hep C during the next decade
Join three of Canada’s prominent physicians, Drs. Allan Ronald, Joel Kettner and Julio Montaner, for a webinar that explores the topic of Treatment as Prevention for TB, Hepatitis C and HIV/AIDS.
Mycobacterium Tuberculosis Surveillance in Canada